Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Urso

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapyRiccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric studyAngelina Cistaro, Natale Quartuccio, Maria Carmen Garganese, et al.
Therapeutic Advances in Urology|March 14, 2025
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)Fabio Matrone, Luca Urso, Rossano Girometti, et al.
Radiology. Imaging Cancer|May 16, 2025
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT StudyFrancesco Lanfranchi, Liliana Belgioia, Domenico Albano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2024
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT CohortMatteo Bauckneht, Liliana Belgioia, Domenico Albano, et al.
Cancers|February 11, 2023
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid TumorsLaura Evangelista, Andrea Bianchi, Alessio Annovazzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 25, 2023
Can Baseline [<sup>18</sup>F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective StudyAndrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, et al.
Cancers|February 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerOttavia De Simoni, Melania Scarpa, Francesco Cavallin, et al.
Cancers|June 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 StudyLorenzo Dell'Atti, Andromachi Kotsafti, Francesca Galuppini, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapyRiccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2021
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric studyAngelina Cistaro, Natale Quartuccio, Maria Carmen Garganese, et al.
Therapeutic Advances in Urology|March 14, 2025
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)Fabio Matrone, Luca Urso, Rossano Girometti, et al.
Radiology. Imaging Cancer|May 16, 2025
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT StudyFrancesco Lanfranchi, Liliana Belgioia, Domenico Albano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 21, 2024
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study)Matteo Bauckneht, Francesco Lanfranchi, Domenico Albano, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT CohortMatteo Bauckneht, Liliana Belgioia, Domenico Albano, et al.
Cancers|February 11, 2023
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid TumorsLaura Evangelista, Andrea Bianchi, Alessio Annovazzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 25, 2023
Can Baseline [<sup>18</sup>F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective StudyAndrea Bianchi, Maria Luisa De Rimini, Rosa Sciuto, et al.
Cancers|February 27, 2026
IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerOttavia De Simoni, Melania Scarpa, Francesco Cavallin, et al.
Cancers|June 26, 2026
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 StudyLorenzo Dell'Atti, Andromachi Kotsafti, Francesca Galuppini, et al.
Pageof 10